HIV/HCV co-infection: pathogenesis, clinical complications, treatment, and new therapeutic technologies

Eva A Operskalski1, Andrea Kovacs

  • 1Maternal Child and Adolescent Center for Infectious Diseases and Virology, Department of Pediatrics, Keck School of Medicine, University of Southern California, Los Angeles, 90033, USA. eva@usc.edu

Current HIV/AIDS Reports
|January 12, 2011
PubMed

Insights

Hepatitis C virus (HCV) and human immunodeficiency virus (HIV) coinfection significantly impacts liver disease progression. New research reviews pathogenesis, co-infection effects, and updated treatment strategies for HIV/HCV.

Area of Science:

  • Hepatology and Virology
  • Immunology
  • Infectious Diseases

Background:

  • Hepatitis C virus (HCV) affects 130 million globally, with 3-5 million coinfected with HIV.
  • HIV accelerates HCV progression, leading to liver disease and death.
  • HCV's impact on HIV progression remains debated, but HCV-related diseases are key concerns in coinfected individuals on antiretroviral therapy.

Purpose of the Study:

  • To review current research on HIV/HCV coinfection pathogenesis.
  • To analyze the effects of coinfection on HIV disease, liver health, immune function, and other organ systems.
  • To evaluate current and novel therapeutic strategies for HIV and HCV in coinfected patients.

Main Methods:

  • Comprehensive literature review of recent studies.
  • Analysis of pathogenesis, clinical outcomes, and treatment efficacy.
  • Synthesis of data on viral interactions and host responses.

Main Results:

  • HIV negatively impacts HCV natural history, increasing viral load and fibrosis.
  • HCV's effect on HIV progression is under investigation, though survival has improved with antiretroviral therapy.
  • HCV-associated liver disease is a major comorbidity in coinfected individuals.

Conclusions:

  • HIV/HCV coinfection presents complex challenges requiring integrated management.
  • Further research is needed to fully understand HCV's impact on HIV and to optimize treatment strategies.
  • Effective antiretroviral therapy has improved survival, highlighting the importance of managing HCV-related complications.

Related Concept Videos

Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Viral Hepatitis I: Introduction01:28

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...
Retrovirus Life Cycles01:10

Retrovirus Life Cycles

Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the retrovirus to...
Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
Inhibitors of Virion Maturation and Assembly01:19

Inhibitors of Virion Maturation and Assembly

As part of their replication cycle, certain viruses synthesize long precursor proteins called polyproteins within infected host cells. In human immunodeficiency virus (HIV), two major polyproteins are produced: Gag and Gag-Pol. The Gag polyprotein supplies the structural components of the virus, while Gag-Pol includes essential viral enzymes such as reverse transcriptase, integrase, and protease. After synthesis, these polyproteins move to the host cell membrane, where they assemble into an...
Sexually Transmitted Infections01:26

Sexually Transmitted Infections

Sexually transmitted infections (STIs) are diseases transmitted primarily through unsafe sexual interactions. Bacteria, viruses, or parasites cause them and can result in severe health complications if untreated.ChlamydiaThe bacterium Chlamydia trachomatis is responsible for the disease Chlamydia, the most common STI in the United States. This peculiar pathogen requires human cells to reproduce, residing intracellularly. The initial infection often goes unnoticed because it typically does not...